SETBP1 and chronic myelomonocytic leukemia: In CMML, 36% (9/25) of patients with ASXL1 mutations carried SETBP1 mutations, while 81.8% (9/11) of patients with SETBP1 mutations were positive for ASXL1 mutations (Mason et al., 2016).